NOS3 and Alzheimer disease: In similar studies, HTN was pharmacologically induced by eNOS inhibition in conjunction with administration of angiotensin II in the Tg2576 mouse model of AD-like pathology (Passos et al., 2016; Nyúl-Tóth et al., 2020).